242 related articles for article (PubMed ID: 29321510)
21. FoxO3 an important player in fibrogenesis and therapeutic target for idiopathic pulmonary fibrosis.
Al-Tamari HM; Dabral S; Schmall A; Sarvari P; Ruppert C; Paik J; DePinho RA; Grimminger F; Eickelberg O; Guenther A; Seeger W; Savai R; Pullamsetti SS
EMBO Mol Med; 2018 Feb; 10(2):276-293. PubMed ID: 29217661
[TBL] [Abstract][Full Text] [Related]
22. Reactive oxygen species are required for maintenance and differentiation of primary lung fibroblasts in idiopathic pulmonary fibrosis.
Bocchino M; Agnese S; Fagone E; Svegliati S; Grieco D; Vancheri C; Gabrielli A; Sanduzzi A; Avvedimento EV
PLoS One; 2010 Nov; 5(11):e14003. PubMed ID: 21103368
[TBL] [Abstract][Full Text] [Related]
23. HDAC8 inhibition ameliorates pulmonary fibrosis.
Saito S; Zhuang Y; Suzuki T; Ota Y; Bateman ME; Alkhatib AL; Morris GF; Lasky JA
Am J Physiol Lung Cell Mol Physiol; 2019 Jan; 316(1):L175-L186. PubMed ID: 30358439
[TBL] [Abstract][Full Text] [Related]
24. CCN5 overexpression inhibits profibrotic phenotypes via the PI3K/Akt signaling pathway in lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis and in an in vivo model of lung fibrosis.
Zhang L; Li Y; Liang C; Yang W
Int J Mol Med; 2014 Feb; 33(2):478-86. PubMed ID: 24276150
[TBL] [Abstract][Full Text] [Related]
25. Human antigen R promotes lung fibroblast differentiation to myofibroblasts and increases extracellular matrix production.
Al-Habeeb F; Aloufi N; Traboulsi H; Liu X; Nair P; Haston C; Azuelos I; Huang SK; White ES; Gallouzi IE; Di Marco S; Eidelman DH; Baglole CJ
J Cell Physiol; 2021 Oct; 236(10):6836-6851. PubMed ID: 33855709
[TBL] [Abstract][Full Text] [Related]
26. Novel differences in gene expression and functional capabilities of myofibroblast populations in idiopathic pulmonary fibrosis.
Walsh SM; Worrell JC; Fabre A; Hinz B; Kane R; Keane MP
Am J Physiol Lung Cell Mol Physiol; 2018 Nov; 315(5):L697-L710. PubMed ID: 30091381
[TBL] [Abstract][Full Text] [Related]
27. KCa3.1 ion channel: A novel therapeutic target for corneal fibrosis.
Anumanthan G; Gupta S; Fink MK; Hesemann NP; Bowles DK; McDaniel LM; Muhammad M; Mohan RR
PLoS One; 2018; 13(3):e0192145. PubMed ID: 29554088
[TBL] [Abstract][Full Text] [Related]
28. Hsp90 regulation of fibroblast activation in pulmonary fibrosis.
Sontake V; Wang Y; Kasam RK; Sinner D; Reddy GB; Naren AP; McCormack FX; White ES; Jegga AG; Madala SK
JCI Insight; 2017 Feb; 2(4):e91454. PubMed ID: 28239659
[TBL] [Abstract][Full Text] [Related]
29. Reversion of in vivo fibrogenesis by novel chromone scaffolds.
Kim HS; Yoon YM; Meang MK; Park YE; Lee JY; Lee TH; Lee JE; Kim IH; Youn BS
EBioMedicine; 2019 Jan; 39():484-496. PubMed ID: 30611717
[TBL] [Abstract][Full Text] [Related]
30. YAP1/Twist promotes fibroblast activation and lung fibrosis that conferred by miR-15a loss in IPF.
Chen Y; Zhao X; Sun J; Su W; Zhang L; Li Y; Liu Y; Zhang L; Lu Y; Shan H; Liang H
Cell Death Differ; 2019 Sep; 26(9):1832-1844. PubMed ID: 30644438
[TBL] [Abstract][Full Text] [Related]
31. miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis.
Liu G; Friggeri A; Yang Y; Milosevic J; Ding Q; Thannickal VJ; Kaminski N; Abraham E
J Exp Med; 2010 Aug; 207(8):1589-97. PubMed ID: 20643828
[TBL] [Abstract][Full Text] [Related]
32. Targeted regulation of fibroblast state by CRISPR-mediated CEBPA expression.
Liu W; Meridew JA; Aravamudhan A; Ligresti G; Tschumperlin DJ; Tan Q
Respir Res; 2019 Dec; 20(1):281. PubMed ID: 31829168
[TBL] [Abstract][Full Text] [Related]
33. Lung fibrosis-associated soluble mediators and bronchoalveolar lavage from idiopathic pulmonary fibrosis patients promote the expression of fibrogenic factors in subepithelial lung myofibroblasts.
Bouros E; Filidou E; Arvanitidis K; Mikroulis D; Steiropoulos P; Bamias G; Bouros D; Kolios G
Pulm Pharmacol Ther; 2017 Oct; 46():78-87. PubMed ID: 28865842
[TBL] [Abstract][Full Text] [Related]
34. Arsenic trioxide inhibits the functions of lung fibroblasts derived from patients with idiopathic pulmonary fibrosis.
Joannes A; Morzadec C; Duclos M; Gutierrez FL; Chiforeanu DC; Le Naoures C; De Latour B; Rouzé S; Wollin L; Jouneau S; Vernhet L
Toxicol Appl Pharmacol; 2022 Apr; 441():115972. PubMed ID: 35276128
[TBL] [Abstract][Full Text] [Related]
35. P311 Promotes Lung Fibrosis via Stimulation of Transforming Growth Factor-β1, -β2, and -β3 Translation.
Duan FF; Barron G; Meliton A; Mutlu GM; Dulin NO; Schuger L
Am J Respir Cell Mol Biol; 2019 Feb; 60(2):221-231. PubMed ID: 30230348
[TBL] [Abstract][Full Text] [Related]
36. Dysregulated Collagen Homeostasis by Matrix Stiffening and TGF-β1 in Fibroblasts from Idiopathic Pulmonary Fibrosis Patients: Role of FAK/Akt.
Giménez A; Duch P; Puig M; Gabasa M; Xaubet A; Alcaraz J
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29144435
[TBL] [Abstract][Full Text] [Related]
37. Protein Tyrosine Phosphatase-N13 Promotes Myofibroblast Resistance to Apoptosis in Idiopathic Pulmonary Fibrosis.
Bamberg A; Redente EF; Groshong SD; Tuder RM; Cool CD; Keith RC; Edelman BL; Black BP; Cosgrove GP; Wynes MW; Curran-Everett D; De Langhe S; Ortiz LA; Thorburn A; Riches DWH
Am J Respir Crit Care Med; 2018 Oct; 198(7):914-927. PubMed ID: 29727583
[TBL] [Abstract][Full Text] [Related]
38. Intratracheal bleomycin causes airway remodeling and airflow obstruction in mice.
Polosukhin VV; Degryse AL; Newcomb DC; Jones BR; Ware LB; Lee JW; Loyd JE; Blackwell TS; Lawson WE
Exp Lung Res; 2012 Apr; 38(3):135-46. PubMed ID: 22394287
[TBL] [Abstract][Full Text] [Related]
39. Olodaterol shows anti-fibrotic efficacy in in vitro and in vivo models of pulmonary fibrosis.
Herrmann FE; Wollin L; Wirth J; Gantner F; Lämmle B; Wex E
Br J Pharmacol; 2017 Nov; 174(21):3848-3864. PubMed ID: 28810065
[TBL] [Abstract][Full Text] [Related]
40. Ca
Roach KM; Bradding P
Br J Pharmacol; 2020 Mar; 177(5):1003-1024. PubMed ID: 31758702
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
